StonvexLoading…
StonvexStonvexStonvexCore line items from IOSP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $464.41M | $453.20M | $1.78B | $1.32B | $880.50M |
Operating Income | Not available | $36.50M | $129.50M | $82.70M | $76.80M |
Net Income | Not available | $30.40M | $116.60M | $69.20M | $56.30M |
EPS (Diluted) | $1.13 | $1.22 | $4.67 | $2.76 | $2.24 |
Total Assets | Not available | $1.82B | $1.83B | $1.80B | $1.81B |
Total Liabilities | Not available | $467.60M | $499.50M | $496.50M | $504.60M |
Cash & Equivalents | Not available | $289.10M | $292.50M | $270.80M | $266.60M |
Free Cash Flow OCF − CapEx | Not available | $8.70M | $88.00M | $41.20M | $16.20M |
Shares Outstanding | Not available | 24.84M | 24.99M | 25.05M | 25.10M |